gadolinium dtpa has been researched along with Uremia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujisaki, K; Hirakawa, N; Iida, M; Komune, N; Komune, S; Kura-Nakamura, N; Ono-Fujisaki, A; Tsuruya, K | 1 |
| Matchett, WJ; McFarland, DR; Moursi, MM; Russell, DK; Sailors, DM | 1 |
| Almén, T; Elmståhl, B; Golman, K; Leander, P; Nilsson, M; Nyman, U | 1 |
1 review(s) available for gadolinium dtpa and Uremia
| Article | Year |
|---|---|
Are gadolinium-based contrast media really safer than iodinated media for digital subtraction angiography in patients with azotemia?
Topics: Angiography, Digital Subtraction; Chelating Agents; Contrast Media; Gadolinium DTPA; Humans; Kidney Diseases; Radiology, Interventional; Triiodobenzoic Acids; Uremia | 2002 |
2 other study(ies) available for gadolinium dtpa and Uremia
| Article | Year |
|---|---|
Rapid deterioration of renal insufficiency after magnetic resonance imaging with gadolinium-based contrast agent.
Topics: Acute Kidney Injury; Aged, 80 and over; Contrast Media; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Mouth Neoplasms; Pulmonary Edema; Renal Dialysis; Renal Insufficiency; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Uremia | 2011 |
Azotemia: gadopentetate dimeglumine as contrast agent at digital subtraction angiography.
Topics: Aged; Aged, 80 and over; Angiography, Digital Subtraction; Aortic Aneurysm, Abdominal; Contrast Media; Drug Combinations; Gadolinium DTPA; Humans; Kidney; Male; Meglumine; Organometallic Compounds; Pentetic Acid; Renal Artery Obstruction; Uremia | 1996 |